These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 33293641)

  • 21. Lateral Organization of Influenza Virus Proteins in the Budozone Region of the Plasma Membrane.
    Leser GP; Lamb RA
    J Virol; 2017 May; 91(9):. PubMed ID: 28202765
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Novel Role for PDZ-Binding Motif of Influenza A Virus Nonstructural Protein 1 in Regulation of Host Susceptibility to Postinfluenza Bacterial Superinfections.
    Shepardson K; Larson K; Cho H; Johns LL; Malkoc Z; Stanek K; Wellhman J; Zaiser S; Daggs-Olson J; Moodie T; Klonoski JM; Huber VC; Rynda-Apple A
    Viral Immunol; 2019 Apr; 32(3):131-143. PubMed ID: 30822217
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human T-cells directed to seasonal influenza A virus cross-react with 2009 pandemic influenza A (H1N1) and swine-origin triple-reassortant H3N2 influenza viruses.
    Hillaire MLB; Vogelzang-van Trierum SE; Kreijtz JHCM; de Mutsert G; Fouchier RAM; Osterhaus ADME; Rimmelzwaan GF
    J Gen Virol; 2013 Mar; 94(Pt 3):583-592. PubMed ID: 23152369
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibodies Directed toward Neuraminidase N1 Control Disease in a Mouse Model of Influenza.
    Job ER; Schotsaert M; Ibañez LI; Smet A; Ysenbaert T; Roose K; Dai M; de Haan CAM; Kleanthous H; Vogel TU; Saelens X
    J Virol; 2018 Feb; 92(4):. PubMed ID: 29167342
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Variation at Extra-epitopic Amino Acid Residues Influences Suppression of Influenza Virus Replication by M1
    van de Sandt CE; Pronk MR; van Baalen CA; Fouchier RAM; Rimmelzwaan GF
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29593036
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Viral neuraminidase treatment of dendritic cells enhances antigen-specific CD8(+) T cell proliferation, but does not account for the CD4(+) T cell independence of the CD8(+) T cell response during influenza virus infection.
    Oh S; Belz GT; Eichelberger MC
    Virology; 2001 Aug; 286(2):403-11. PubMed ID: 11485408
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-Lasting Cross-Protection Against Influenza A by Neuraminidase and M2e-based immunization strategies.
    Schotsaert M; Ysenbaert T; Smet A; Schepens B; Vanderschaeghe D; Stegalkina S; Vogel TU; Callewaert N; Fiers W; Saelens X
    Sci Rep; 2016 Apr; 6():24402. PubMed ID: 27072615
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influenza Neuraminidase Subtype N1: Immunobiological Properties and Functional Assays for Specific Antibody Response.
    Changsom D; Lerdsamran H; Wiriyarat W; Chakritbudsabong W; Siridechadilok B; Prasertsopon J; Noisumdaeng P; Masamae W; Puthavathana P
    PLoS One; 2016; 11(4):e0153183. PubMed ID: 27054879
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influenza A virus directly modulates mouse eosinophil responses.
    LeMessurier KS; Rooney R; Ghoneim HE; Liu B; Li K; Smallwood HS; Samarasinghe AE
    J Leukoc Biol; 2020 Jul; 108(1):151-168. PubMed ID: 32386457
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of Influenza A Virus Infection by Fucoidan Targeting Viral Neuraminidase and Cellular EGFR Pathway.
    Wang W; Wu J; Zhang X; Hao C; Zhao X; Jiao G; Shan X; Tai W; Yu G
    Sci Rep; 2017 Jan; 7():40760. PubMed ID: 28094330
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of Ongoing Influenza A Virus Replication Reveals Different Mechanisms of RIG-I Activation.
    Liu G; Lu Y; Liu Q; Zhou Y
    J Virol; 2019 Mar; 93(6):. PubMed ID: 30602605
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BST-2 restricts IAV release and is countered by the viral M2 protein.
    Hu S; Yin L; Mei S; Li J; Xu F; Sun H; Liu X; Cen S; Liang C; Li A; Guo F
    Biochem J; 2017 Feb; 474(5):715-730. PubMed ID: 28087685
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Conserved Residue, Tyrosine (Y) 84, in H5N1 Influenza A Virus NS1 Regulates IFN Signaling Responses to Enhance Viral Infection.
    Wang BX; Wei L; Kotra LP; Brown EG; Fish EN
    Viruses; 2017 May; 9(5):. PubMed ID: 28498306
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PARP1 Enhances Influenza A Virus Propagation by Facilitating Degradation of Host Type I Interferon Receptor.
    Xia C; Wolf JJ; Sun C; Xu M; Studstill CJ; Chen J; Ngo H; Zhu H; Hahm B
    J Virol; 2020 Mar; 94(7):. PubMed ID: 31915279
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuraminidase inhibitor susceptibility and neuraminidase enzyme kinetics of human influenza A and B viruses circulating in Thailand in 2010-2015.
    Tewawong N; Marathe BM; Poovorawan Y; Vongpunsawad S; Webby RJ; Govorkova EA
    PLoS One; 2018; 13(1):e0190877. PubMed ID: 29324781
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutation of the second sialic acid-binding site of influenza A virus neuraminidase drives compensatory mutations in hemagglutinin.
    Du W; Wolfert MA; Peeters B; van Kuppeveld FJM; Boons GJ; de Vries E; de Haan CAM
    PLoS Pathog; 2020 Aug; 16(8):e1008816. PubMed ID: 32853241
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cross-Reactive Neuraminidase-Inhibiting Antibodies Elicited by Immunization with Recombinant Neuraminidase Proteins of H5N1 and Pandemic H1N1 Influenza A Viruses.
    Liu WC; Lin CY; Tsou YT; Jan JT; Wu SC
    J Virol; 2015 Jul; 89(14):7224-34. PubMed ID: 25948745
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Complement-Independent Modulation of Influenza A Virus Infection by Factor H.
    Murugaiah V; Varghese PM; Saleh SM; Tsolaki AG; Alrokayan SH; Khan HA; Collison KS; Sim RB; Nal B; Al-Mohanna FA; Kishore U
    Front Immunol; 2020; 11():355. PubMed ID: 32269562
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Bivalent Heterologous DNA Virus-Like-Particle Prime-Boost Vaccine Elicits Broad Protection against both Group 1 and 2 Influenza A Viruses.
    Jiang W; Wang S; Chen H; Ren H; Huang X; Wang G; Chen Z; Chen L; Chen Z; Zhou P
    J Virol; 2017 May; 91(9):. PubMed ID: 28179535
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutations in Influenza A Virus Neuraminidase and Hemagglutinin Confer Resistance against a Broadly Neutralizing Hemagglutinin Stem Antibody.
    Prachanronarong KL; Canale AS; Liu P; Somasundaran M; Hou S; Poh YP; Han T; Zhu Q; Renzette N; Zeldovich KB; Kowalik TF; Kurt-Yilmaz N; Jensen JD; Bolon DNA; Marasco WA; Finberg RW; Schiffer CA; Wang JP
    J Virol; 2019 Jan; 93(2):. PubMed ID: 30381484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.